organization · Reporting owner
Medpace Investors, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | 10% owner | March 06, 2024 | March 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date March 06, 2024 · Filed March 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,733,019 |
Ending reported balance
After 2024-03-08 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-03-06 · Sale · Disposed 100,000 · Balance 4,833,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. Row 2 · 2024-03-07 · Sale · Disposed 75,000 · Balance 4,758,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. Row 3 · 2024-03-08 · Sale · Disposed 25,000 · Balance 4,733,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F4: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F4: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2022 Filed Sep 6, 2022 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseCommon Stock | 42,076 | $144.52 | $6,080,823.52 |
DisclosureSEC source: 0001567619-22-017049 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,555,715 F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2022, and amended on May 3, 2022. F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $143.20 to $145.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 20:01 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseCommon Stock | 8,330 | $145.00 | $1,207,850.00 |
DisclosureSEC source: 0001567619-22-014238 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513,639 F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2022, and amended on May 3, 2022. F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $144.885 to $145.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 14, 2022 Filed Jul 18, 2022 20:04 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseCommon Stock | 22,290 | $144.59 | $3,222,911.10 |
DisclosureSEC source: 0001567619-22-014111 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,505,309 F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2022, and amended on May 3, 2022. F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $142.97 to $145.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 21:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,338 | $213.44 | $712,462.72 |
DisclosureSEC source: 0001567619-22-000729 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,483,019 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $216.175. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 19,744 | $212.70 | $4,199,548.80 |
DisclosureSEC source: 0001567619-22-000224 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,486,357 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $217.36. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 13,069 | $219.14 | $2,863,940.66 |
DisclosureSEC source: 0001567619-22-000224 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,506,101 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $217.48 to $220.44. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 30, 2021 Filed Jan 4, 2022 21:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 17,376 | $220.34 | $3,828,627.84 |
DisclosureSEC source: 0001567619-22-000224 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,519,170 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $218.835 to $222.14. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 19:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 16,750 | $220.16 | $3,687,680.00 |
DisclosureSEC source: 0001567619-21-022665 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,536,546 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $217.635 to $221.125. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 19:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 24,118 | $222.18 | $5,358,537.24 |
DisclosureSEC source: 0001567619-21-022665 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,553,296 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $218.395 to $229.14. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 21:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 39,171 | $226.11 | $8,856,954.81 |
DisclosureSEC source: 0001567619-21-022563 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,577,414 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $223.28 to $227.87. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 23, 2021 Filed Dec 28, 2021 21:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 22,830 | $223.19 | $5,095,427.70 |
DisclosureSEC source: 0001567619-21-022563 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,616,585 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $219.94 to $224.68. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 19:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 38,960 | $220.50 | $8,590,680.00 |
DisclosureSEC source: 0001567619-21-022494 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,639,415 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $217.08 to $222.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 19:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 18,133 | $215.17 | $3,901,677.61 |
DisclosureSEC source: 0001567619-21-022494 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,678,375 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.785 to $217.53. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 21:43 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 22,734 | $212.57 | $4,832,566.38 |
DisclosureSEC source: 0001567619-21-022407 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,696,508 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $215.12. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 21:43 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 30,605 | $213.59 | $6,536,921.95 |
DisclosureSEC source: 0001567619-21-022407 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,719,242 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $215.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 5,959 | $210.22 | $1,252,700.98 |
DisclosureSEC source: 0001567619-21-022250 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,749,847 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $211.175. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 2,424 | $210.28 | $509,718.72 |
DisclosureSEC source: 0001567619-21-022250 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,755,806 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $210.5425. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 21:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 309 | $210.20 | $64,951.80 |
DisclosureSEC source: 0001567619-21-021934 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,758,230 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $210.90. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 14,994 | $212.13 | $3,180,677.22 |
DisclosureSEC source: 0001567619-21-021934 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,758,539 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $213.455. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 08, 2021 Filed Dec 9, 2021 21:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 15,871 | $212.89 | $3,378,777.19 |
DisclosureSEC source: 0001567619-21-021831 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,773,533 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $214.46. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 18,520 | $211.78 | $3,922,165.60 |
DisclosureSEC source: 0001567619-21-021831 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,789,404 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $213.80. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 400 | $211.48 | $84,592.00 |
DisclosureSEC source: 0001567619-21-021705 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,807,924 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.25 to $211.92. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 21:01 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 6,090 | $210.79 | $1,283,711.10 |
DisclosureSEC source: 0001567619-21-021580 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,808,324 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $211.49. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:01 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 26,642 | $211.57 | $5,636,647.94 |
DisclosureSEC source: 0001567619-21-021580 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,814,414 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $214.80. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| November 30, 2021 Filed Dec 1, 2021 21:23 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 197 | $210.29 | $41,427.13 |
DisclosureSEC source: 0001567619-21-021382 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,841,056 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 21:23 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 12,115 | $212.10 | $2,569,591.50 |
DisclosureSEC source: 0001567619-21-021382 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,841,253 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $214.345. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| November 26, 2021 Filed Nov 29, 2021 21:21 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 15,071 | $210.99 | $3,179,830.29 |
DisclosureSEC source: 0001567619-21-021225 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,853,368 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $214.27. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:21 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 14,578 | $213.26 | $3,108,904.28 |
DisclosureSEC source: 0001567619-21-021225 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,868,439 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.25 to $214.86. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 19:46 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 26,057 | $212.64 | $5,540,760.48 |
DisclosureSEC source: 0001567619-21-021145 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,883,017 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $221.11. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 19:46 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 48,128 | $224.33 | $10,796,554.24 |
DisclosureSEC source: 0001567619-21-021145 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,909,074 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $219.65 to $229.19. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 03, 2021 Filed Sep 7, 2021 20:26 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 604 | $191.82 | $115,859.28 |
DisclosureSEC source: 0001567619-21-016794 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,957,202 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $190.76 to $192.87. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 20:26 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 30,234 | $191.85 | $5,800,392.90 |
DisclosureSEC source: 0001567619-21-016794 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,957,806 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $186.49 to $194.04. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:03 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 14,304 | $186.29 | $2,664,692.16 |
DisclosureSEC source: 0001567619-21-016648 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,988,040 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.575 to $187.78. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:03 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 12,675 | $182.04 | $2,307,357.00 |
DisclosureSEC source: 0001567619-21-016648 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,002,344 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.82 to $185.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 12,236 | $183.14 | $2,240,901.04 |
DisclosureSEC source: 0001567619-21-016508 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,015,019 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.57 to $184.80. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 11,840 | $181.83 | $2,152,867.20 |
DisclosureSEC source: 0001567619-21-016508 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,027,255 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.4175 to $183.86. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 466 | $180.17 | $83,959.22 |
DisclosureSEC source: 0001567619-21-016409 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,039,095 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $180.59. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,622 | $180.54 | $1,376,075.88 |
DisclosureSEC source: 0001567619-21-016409 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,039,561 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $181.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 24, 2021 Filed Aug 25, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,814 | $180.06 | $326,628.84 |
DisclosureSEC source: 0001567619-21-016329 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,047,183 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $180.37. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,482 | $180.22 | $267,086.04 |
DisclosureSEC source: 0001567619-21-016329 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,048,997 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $180.94. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 2,301 | $180.49 | $415,307.49 |
DisclosureSEC source: 0001567619-21-016173 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,050,479 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $181.40. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 20:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 5,246 | $182.10 | $955,296.60 |
DisclosureSEC source: 0001567619-21-016058 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,052,780 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $184.35. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 16,817 | $182.83 | $3,074,652.11 |
DisclosureSEC source: 0001567619-21-016058 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,058,026 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $185.08. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:23 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 556 | $180.04 | $100,102.24 |
DisclosureSEC source: 0001567619-21-014738 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,074,843 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $180.10. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 20:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 131 | $180.93 | $23,701.83 |
DisclosureSEC source: 0001567619-21-014097 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,075,399 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 20:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 15,209 | $181.47 | $2,759,977.23 |
DisclosureSEC source: 0001567619-21-014097 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,075,530 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.86. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 20:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 18,882 | $181.21 | $3,421,607.22 |
DisclosureSEC source: 0001567619-21-013969 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,090,739 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $182.33. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 20:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 8,516 | $180.63 | $1,538,245.08 |
DisclosureSEC source: 0001567619-21-013969 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,109,621 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $183.89. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 21, 2021 Filed Jul 22, 2021 20:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 9,206 | $182.42 | $1,679,358.52 |
DisclosureSEC source: 0001567619-21-013842 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,118,137 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.325 to $184.27. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 20, 2021 Filed Jul 22, 2021 20:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 10,176 | $183.06 | $1,862,818.56 |
DisclosureSEC source: 0001567619-21-013842 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,127,343 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $184.45. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.